Federation des caisses Desjardins du Quebec’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.2M | Sell |
113,130
-2,530
| -2% | -$318K | 0.06% | 208 |
|
|
2025
Q1 | $12.8M | Sell |
115,660
-11,507
| -9% | -$1.27M | 0.06% | 206 |
|
|
2024
Q4 | $17.4M | Sell |
127,167
-12,336
| -9% | -$1.68M | 0.09% | 168 |
|
|
2024
Q3 | $16.1M | Buy |
139,503
+29,768
| +27% | +$3.43M | 0.08% | 176 |
|
|
2024
Q2 | $15.1M | Sell |
109,735
-3,629
| -3% | -$500K | 0.08% | 178 |
|
|
2024
Q1 | $15.6M | Sell |
113,364
-58,404
| -34% | -$8.05M | 0.11% | 161 |
|
|
2023
Q4 | $22.6M | Sell |
171,768
-4,645
| -3% | -$612K | 0.21% | 112 |
|
|
2023
Q3 | $19.8M | Buy |
176,413
+1,998
| +1% | +$225K | 0.2% | 112 |
|
|
2023
Q2 | $16.4M | Buy |
174,415
+164,905
| +1,734% | +$15.6M | 0.16% | 131 |
|
|
2023
Q1 | $963K | Buy |
9,510
+8,207
| +630% | +$831K | 0.01% | 607 |
|
|
2022
Q4 | $156K | Buy |
1,303
+333
| +34% | +$39.8K | ﹤0.01% | 1124 |
|
|
2022
Q3 | $103K | Hold |
970
| – | – | ﹤0.01% | 1307 |
|
|
2022
Q2 | $94.6K | Buy |
+970
| New | +$94.6K | ﹤0.01% | 1360 |
|
|
2021
Q2 | – | Sell |
-415
| Closed | -$40.4K | – | 2553 |
|
|
2021
Q1 | $40.4K | Hold |
415
| – | – | ﹤0.01% | 1607 |
|
|
2020
Q4 | $39.8K | Buy |
415
+412
| +13,733% | +$39.5K | ﹤0.01% | 1552 |
|
|
2020
Q3 | $288 | Buy |
+3
| New | +$288 | ﹤0.01% | 2104 |
|
|
2020
Q2 | – | Sell |
-8
| Closed | -$692 | – | 2215 |
|
|
2020
Q1 | $692 | Hold |
8
| – | – | ﹤0.01% | 2089 |
|
|
2019
Q4 | $860 | Hold |
8
| – | – | ﹤0.01% | 2209 |
|
|
2019
Q3 | $721 | Buy |
+8
| New | +$721 | ﹤0.01% | 2173 |
|
|
2018
Q4 | – | Sell |
-778
| Closed | -$95.7K | – | 2120 |
|
|
2018
Q3 | $95.7K | Buy |
+778
| New | +$95.7K | ﹤0.01% | 1196 |
|
|
2018
Q2 | – | Sell |
-475
| Closed | -$39.4K | – | 2212 |
|
|
2018
Q1 | $39.4K | Buy |
+475
| New | +$39.4K | ﹤0.01% | 1391 |
|